Companies: 10,795·Total market cap: $144.5T
Opthea Limited

Opthea Limited

CKDXFOTCHealthcare● Active
$0.44
+$0.00(+0.00%)
Market Cap$601910336
P/E Ratio
52W High$0.44
52W Low$0.01

Opthea Limited (CKDXF) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

CKDXF · cash on hand · updated Jun 30, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$48.4M -71.9% vs prior year
FY · as of Jun 30, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$48.4M
cashAndCashEquivalents
Short-Term Investments
$0
shortTermInvestments
YoY Change vs Prior Year
-71.9%
vs prior fiscal year
Latest Quarter
$48.6M
Q2 2025
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: June 30, 2025

Net cash vs debt

Cash & ST Investments$48.4MCash on Hand
Total Debt$247.8MTotal Debt
Net Cash / Net Debt−$199.4MNet Debt Position
Cash vs Debt Ratio
Cash 16%Debt 84%

Opthea Limited carries a net debt position of $199.4M. Total debt ($247.8M) exceeds cash on hand ($48.4M). Opthea Limited cash vs debt ratio: 16% cash / 84% debt.

Net Cash = Cash & ST Investments − Total Debt$48.4M$247.8M = −$199.4M

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
CKDXF annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Jun 30, 2025Latest$48.4M-71.9%
Jun 30, 2024$172.5M+28.7%
Jun 30, 2023$134.0M+200.2%
Jun 30, 2022$44.6M-62.2%
Jun 30, 2021$118.2M+90.6%
CKDXF cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.6%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%
#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%
#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
Opthea Limited
Opthea LimitedYOU
CKDXF
$48.4M8.1%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Opthea Limited (CKDXF) cash on hand as of June 30, 2025 is $48.4M, comprising $48.4M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Opthea Limited cash and short-term investments on the balance sheet (10-K filing). Also referred to as Opthea Limited cash reserves or cash position.

Opthea Limited annual cash on hand history shows decreased -71.9% in 2025: decreased -71.9% in 2025. Opthea Limited cash reserves in 2025 reflect the company's capital allocation strategy.

Opthea Limited carries total debt of $247.8M against cash of $48.4M, resulting in a net debt position of -$199.4M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Frequently asked questions

CKDXF cash on hand · 5 questions

As of June 30, 2025, Opthea Limited (CKDXF) has $48,443,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $48,443,000 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (June 30, 2025): $48,607,839. Data sourced from the annual 10-K filing via FMP.

CKDXF cash on handCKDXF cash reservesCKDXF cash 2025how much cash does CKDXF have

Source: FMP /balance-sheet-statement · US GAAP · Opthea Limited · Opthea Limited SEC 10-K & 10-Q filings · US GAAP · Last updated: June 30, 2025